期刊
CURRENT PHARMACEUTICAL DESIGN
卷 25, 期 44, 页码 4717-4724出版社
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1381612825666191022163237
关键词
Bacterial multidrug resistance; antibiotics; combination therapy; efflux pumps; nanotechnology; infections
资金
- Scientific Research Fund of Ministry of Health - Medical Science Major Technology Fund Project of Zhejiang Province [WKJ-ZJ-1609]
Background: Antibacterial multidrug resistance has emerged as one of the foremost global problems affecting human health. The emergence of resistant infections with the increasing number of multidrug-resistant pathogens has posed a serious problem, which required innovative collaborations across multiple disciplines to address this issue. Methods: In this review, we will explain the mechanisms of bacterial multidrug resistance and discuss different strategies for combating it, including combination therapy, the use of novel natural antibiotics, and the use of nanotechnology in the development of efflux pump inhibitors. Results: While combination therapy will remain the mainstay of bacterial multi-drug resistance treatment, nanotechnology will play critical roles in the development of novel treatments in the coming years. Conclusion: Nanotechnology provides an encouraging platform for the development of clinically relevant and practical strategies to overcome drug resistance in the future.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据